Accendra Health, Inc.
ACH
$3.23
$0.072.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -0.01% | 3.06% | -40.79% | -58.18% | -67.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.01% | 3.06% | -40.79% | -58.18% | -67.85% |
| Cost of Revenue | 3.65% | 5.22% | -53.61% | -70.36% | -78.29% |
| Gross Profit | -4.00% | 0.70% | -14.39% | -24.10% | -32.55% |
| SG&A Expenses | -1.31% | -1.37% | -15.89% | -25.95% | -34.24% |
| Depreciation & Amortization | 101.05% | 11.49% | -58.67% | -53.78% | -57.01% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.80% | 2.49% | -42.97% | -60.05% | -69.34% |
| Operating Income | -37.17% | 12.24% | 10.29% | 0.18% | -10.38% |
| Income Before Tax | 64.30% | 69.09% | -5,680.44% | -1,982.82% | -684.56% |
| Income Tax Expenses | -129.62% | -96.50% | 604.79% | 367.63% | 352.03% |
| Earnings from Continuing Operations | 69.12% | 70.72% | -38,899.91% | -4,665.08% | -1,026.80% |
| Earnings from Discontinued Operations | -3,865.85% | -8,250.43% | -1,819.14% | -2,230.96% | -190.00% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -195.84% | -203.47% | -2,647.63% | -2,734.35% | -843.49% |
| EBIT | -37.17% | 12.24% | 10.29% | 0.18% | -10.38% |
| EBITDA | -1.75% | 10.11% | -19.52% | -25.60% | -30.06% |
| EPS Basic | -195.20% | -202.54% | -2,642.66% | -2,724.61% | -832.93% |
| Normalized Basic EPS | -119.71% | 1.25% | 14.13% | 3.05% | 27.91% |
| EPS Diluted | -195.37% | -202.76% | -2,631.93% | -2,711.96% | -832.39% |
| Normalized Diluted EPS | -119.79% | 2.05% | 16.36% | 3.96% | 29.36% |
| Average Basic Shares Outstanding | -0.15% | 0.43% | 0.59% | 0.82% | 1.06% |
| Average Diluted Shares Outstanding | -0.60% | -0.02% | -0.34% | 0.78% | 1.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |